Who should not take Teriparatide?
Documented caution flags for Teriparatide include paget's disease and prior radiation to bone. This is not exhaustive, and absence from this list is not a safety clearance. Anyone pregnant, nursing, or managing a serious medical condition should only consider it under a doctor's care, and safety data for Teriparatide is limited.
Documented caution flags for Teriparatide
- Paget's disease
- Prior radiation to bone
- Hypercalcemia
- Active malignancy
- Pregnancy / nursing
Reported side effects to weigh
- Nausea
- Mild calcium fluctuations
- Headache
- Leg cramps
References
- Effect of Teriparatide on the risk of fractures in postmenopausal women with osteoporosis — Neer RM et al., NEJM, 2001
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial — Kendler DL, Marin F, Geusens P, et al. — The Lancet, 2018
- FORTEO (teriparatide) injection — FDA Prescribing Information — FDA / DailyMed (Eli Lilly and Company)
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Teriparatide
Last updated 2026-06-15.